In addition, levels of ABCB1 are elevated in post-treatment patients PC samples and in multiple PC cell lines, suggesting that ABCB1 upregulation is a result of acquired resistance [42, 45]. This evidence concerns the gene ABCB1 and pachyonychia congenita.